Takeda Pharmaceutical (TAK) Dividends Paid - Common Growth (5y) (2023 - 2026)
Takeda Pharmaceutical (TAK) Dividends Paid - Common Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.76% |
| Dec 31, 2025 | 5.31% |
| Sep 30, 2025 | 6.02% |
| Jun 30, 2025 | 4.10% |
| Mar 31, 2025 | -5.26% |
| Sep 30, 2024 | 3.87% |
| Jun 30, 2024 | 5.97% |
| Mar 31, 2024 | 8.57% |
| Dec 31, 2023 | -10.40% |
| Sep 30, 2023 | -1.54% |
| Jun 30, 2023 | -9.87% |
| Mar 31, 2023 | 10.10% |